Analyzing chemotherapy-induced peripheral neuropathy in vivo using non-mammalian animal models

Anthony M. Cirrincione, Sandra Rieger

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


Non-mammalian models of CIPN remain relatively sparse, but the knowledge gained from the few published studies suggest that these species have great potential to serve as a discovery platform for new pathways and underlying genetic mechanisms of CIPN. These models permit large-scale genetic and pharmacological screening, and they are highly suitable for in vivo imaging. CIPN phenotypes described in rodents have been confirmed in those models, and conversely, genetic players leading to axon de- and regeneration under conditions of chemotherapy treatment identified in these non-mammalian species have been validated in rodents. Given the need for non-traditional approaches with which to identify new CIPN mechanisms, these models bear a strong potential due to the conservation of basic mechanisms by which chemotherapeutic agents induce neurotoxicity.

Original languageEnglish (US)
Article number113090
JournalExperimental neurology
StatePublished - Jan 2020
Externally publishedYes


  • Axon degeneration
  • Chemotherapy-induced peripheral neuropathy
  • CIPN
  • Drosophila
  • in vivo imaging
  • Non-mammalian
  • Review
  • Zebrafish C. elegans

ASJC Scopus subject areas

  • Neurology
  • Developmental Neuroscience


Dive into the research topics of 'Analyzing chemotherapy-induced peripheral neuropathy in vivo using non-mammalian animal models'. Together they form a unique fingerprint.

Cite this